|
Dimension 1: Crude and adjusted associations between patient characteristics and patients' evaluation of aspects of the doctor-patient relationship. |
|||||||||
| 100% positive assessments 1 |
0–49% positive assessments 2 |
||||||||
|
|
|||||||||
| Prev.(%) |
PR |
Adj. PR |
95% CI |
Prev.(%) |
PR |
Adj. PR |
95% CI |
||
|
|
|||||||||
| Gender |
|||||||||
| (N = 25533) |
Female |
63.8 |
1 |
1 |
14.9 |
1 |
1 |
||
| Male |
65.1 |
1.02 |
0.98 |
0.96 – 1.00 |
13.0 |
0.87 |
0.93 |
0.86 – 1.00 |
|
|
|
|||||||||
| Age (years) |
|||||||||
| (N = 25533) |
18–24 |
52.3 |
1 |
1 |
16.4 |
1 |
1 |
||
| 25–29 |
54.3 |
1.04 |
1.03 |
0.96 – 1.10 |
16.6 |
1.03 |
1.03 |
0.87 – 1.22 |
|
| 30–34 |
57.6 |
1.10 |
1.10 |
1.04 – 1.18 |
16.7 |
1.00 |
0.99 |
0.86 – 1.15 |
|
| 35–39 |
58.8 |
1.12 |
1.15 |
1.08 – 1.22 |
17.0 |
1.01 |
0.96 |
0.82 – 1.13 |
|
| 40–44 |
60.1 |
1.15 |
1.20 |
1.13 – 1.29 |
17.3 |
1.00 |
0.93 |
0.80 – 1.09 |
|
| 45–49 |
61.2 |
1.17 |
1.23 |
1.15 – 1.32 |
16.1 |
0.90 |
0.83 |
0.70 – 0.98 |
|
| 50–54 |
65.2 |
1.25 |
1.33 |
1.25 – 1.42 |
14.2 |
0.88 |
0.71 |
0.60 – 0.85 |
|
| 55–59 |
67.6 |
1.29 |
1.39 |
1.30 – 1.48 |
13.0 |
0.74 |
0.64 |
0.54 – 0.77 |
|
| 60–64 |
70.2 |
1.34 |
1.43 |
1.35 – 1.53 |
11.8 |
0.67 |
0.58 |
0.48 – 0.70 |
|
| 65–69 |
76.8 |
1.47 |
1.57 |
1.47 – 1.67 |
9.4 |
0.58 |
0.47 |
0.38 – 0.58 |
|
| 70–74 |
76.7 |
1.46 |
1.57 |
1.47 – 1.67 |
10.5 |
0.53 |
0.52 |
0.43 – 0.63 |
|
| 75–79 |
73.6 |
1.41 |
1.52 |
1.43 – 1.63 |
11.2 |
0.51 |
0.55 |
0.44 – 0.67 |
|
| 80+ |
72.8 |
1.39 |
1.50 |
1.40 – 1.61 |
10.4 |
0.57 |
0.49 |
0.39 – 0.62 |
|
|
|
|||||||||
| Further education (years) |
|||||||||
| (N = 24364) |
None |
66.3 |
13 |
13 |
13.3 |
1 |
1 |
||
| Less than 2 |
64.5 |
0.94 |
1.01 |
0.97 – 1.05 |
14.8 |
1.12 |
1.05 |
0.92 – 1.19 |
|
| 2–4 |
63.8 |
0.86 |
0.99 |
0.96 – 1.02 |
14.6 |
1.10 |
1.07 |
0.98 – 1.17 |
|
| 5 or more |
62.2 |
0.73 |
0.96 |
0.93 – 1.00 |
14.7 |
1.10 |
1.11 |
0.99 – 1.25 |
|
| Undergoing education or other |
|||||||||
| 66.0 |
0.91 |
1.06 |
1.01 – 1.10 |
12.4 |
0.94 |
0.91 |
0.76 – 1.08 |
||
|
|
|||||||||
| Frequency of attendance (times per year) |
|||||||||
| (N = 25533) |
0–1 |
60.7 |
1 |
1 |
16.4 |
1 |
1 |
||
| 2–3 |
61.9 |
1.02 |
1.04 |
1.00 – 1.07 |
15.7 |
0.95 |
0.91 |
0.82 – 1.01 |
|
| 4–5 |
64.6 |
1.06 |
1.08 |
1.04 – 1.11 |
14.1 |
0.86 |
0.79 |
0.71 – 0.88 |
|
| 6–7 |
65.1 |
1.07 |
1.10 |
1.05 – 1.14 |
14.1 |
0.86 |
0.74 |
0.66 – 0.84 |
|
| 8–9 |
67.5 |
1.11 |
1.14 |
1.09 – 1.19 |
13.0 |
0.79 |
0.67 |
0.58 – 0.77 |
|
| 10+ |
68.2 |
1.12 |
1.18 |
1.14 – 1.23 |
11.4 |
0.69 |
0.53 |
0.46 – 0.61 |
|
|
|
|||||||||
| Duration of listing (years) |
|||||||||
| (N = 16985) |
Less than 1 |
63.2 |
1 |
1 |
16.5 |
1 |
1 |
||
| 1–2 |
64.6 |
1.02 |
1.00 |
0.95 – 1.05 |
13.6 |
0.82 |
0.89 |
0.75 – 1.05 |
|
| 3–7 |
64.6 |
1.02 |
0.98 |
0.94 – 1.02 |
13.7 |
0.83 |
0.92 |
0.80 – 1.07 |
|
| 8–12 |
65.5 |
1.04 |
0.97 |
0.92 – 1.02 |
13.4 |
0.81 |
0.93 |
0.80 – 1.08 |
|
| 13+ |
68.3 |
1.08 |
1.00 |
0.95 – 1.05 |
11.9 |
0.72 |
0.85 |
0.73 – 0.99 |
|
|
|
|||||||||
| Self-rated health |
|||||||||
| (N = 25533) |
Excellent |
67.6 |
1 |
1 |
12.0 |
1 |
1 |
||
| Very good |
64.5 |
0.95 |
0.92 |
0.89 – 0.94 |
12.5 |
1.04 |
1.14 |
1.01 – 1.29 |
|
| Good |
65.0 |
0.96 |
0.83 |
0.81 – 0.86 |
14.6 |
1.22 |
1.66 |
1.46 – 1.87 |
|
| Fair |
61.4 |
0.91 |
0.74 |
0.72 – 0.77 |
17.2 |
1.44 |
2.29 |
2.01 – 2.62 |
|
| Poor |
58.2 |
0.86 |
0.69 |
0.65 – 0.74 |
18.6 |
1.56 |
2.66 |
2.21 – 3.20 |
|
|
|
|||||||||
| Chronic condition |
|||||||||
| (N = 25170) |
No |
62.3 |
1 |
13 |
14.8 |
1 |
1 |
||
| Yes-KRTC |
70.6 |
1.13 |
1.06 |
1.03 – 1.09 |
12.2 |
0.83 |
0.89 |
0.81 – 0.99 |
|
| Yes-other or multiple |
63.9 |
1.03 |
1.04 |
1.01 – 1.06 |
14.7 |
0.99 |
0.89 |
0.82 – 0.96 |
|
|
|
|||||||||
| Chronic condition |
|||||||||
| (N = 17192) |
None |
62.3 |
1 |
13 |
14.8 |
1 |
1 |
||
| K – Cardiovascular |
72.1 |
1.16 |
1.05 |
1.01 – 1.09 |
10.7 |
0.73 |
0.85 |
0.73 – 1.00 |
|
| R – Respiratory |
66.5 |
1.07 |
1.06 |
1.01 – 1.11 |
14.9 |
1.01 |
0.99 |
0.85 – 1.15 |
|
| T – Endocrine |
69.8 |
1.12 |
1.04 |
1.00 – 1.09 |
13.7 |
0.93 |
1.01 |
0.85 – 1.20 |
|
| C – Cancer |
77.7 |
1.25 |
1.20 |
1.12 – 1.28 |
6.6 |
0.44 |
0.46 |
0.29 – 0.73 |
|
|
Prevalence ratio (PR) for 100% positive assessments and for 0–49% positive assessments associated with different patient characteristics. Crude PRs are adjusted for clustering of patients. Adjusted PRs are adjusted for patients' gender, age, frequency of attending a GP, self-rated health and clustering of frequency patients. Numbers in italics are used to indicate statistical significance. 1 Patients who marked 100% of the answered questions in one of the two most positive answering categories. 2 Patients who marked less than 50% (0–49%) of the answered questions in one of the two most positive answering categories. 3 Poisson regression with robust variance | |||||||||
Heje et al. BMC Health Services Research 2008 8:178 doi:10.1186/1472-6963-8-178 |
|||||||||